Authors: PAUL RW LOOMIS A WEISSER K SLOANE DL LAFOE D CLAYTON D ROGERS L OVERALL RW

Citation: Rw. Paul et al., GENE-TRANSFER MEDIATED BY AN ENGINEERED MULTIFUNCTIONAL PROTEIN, Cancer gene therapy, 3(6), 1996, pp. 40-40

Authors: DEMEY C SCHROETER V BUTZER R JAHN P WEISSER K WETTERICH U TERHAAG B MUTSCHLER E SPAHNLANGGUTH H PALM D BELZ GG

Citation: C. Demey et al., DOSE-EFFECT AND KINETIC-DYNAMIC RELATIONSHIPS OF THE BETA-ADRENOCEPTOR BLOCKING PROPERTIES OF VARIOUS DOSES OF TALINOLOL IN HEALTHY HUMANS, Journal of cardiovascular pharmacology, 26(6), 1995, pp. 879-888

Authors: NEUBECK M FLISER D PRITSCH M WEISSER K FLISER M NUSSBERGER J RITZ E MUTSCHLER E

Citation: M. Neubeck et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF LISINOPRIL IN ADVANCED RENAL-FAILURE - CONSEQUENCE OF DOSE ADJUSTMENT, European Journal of Clinical Pharmacology, 46(6), 1994, pp. 537-543

Authors: BAUER D KELLER S WEISSER K

Citation: D. Bauer et al., HYDROFORMING OF ALUMINUM TUBES, Metall, 48(8), 1994, pp. 601-605

Authors: WEISSER K SCHLOOS J

Citation: K. Weisser et J. Schloos, MEASUREMENTS OF SERUM ACE ACTIVITY IN-VITRO AFTER ADMINISTRATION OF ENALAPRIL IN MAN CANNOT REFLECT INHIBITION OF THE ENZYME IN-VIVO, Methods and findings in experimental and clinical pharmacology, 15(6), 1993, pp. 413-418

Authors: WITTE K WEISSER K NEUBECK M MUTSCHLER E LEHMANN K HOPF R LEMMER B

Citation: K. Witte et al., CARDIOVASCULAR EFFECTS, PHARMACOKINETICS, AND CONVERTING-ENZYME INHIBITION OF ENALAPRIL AFTER MORNING VERSUS EVENING ADMINISTRATION, Clinical pharmacology and therapeutics, 54(2), 1993, pp. 177-186